EBMT PLASMA CELL DISORDERS (INCLUDING MULTIPLE MYELOMA)
  • Global rating average: 0.0 out of 5
  • 0.0
  • 0.0
  • 0.0
  • 0.0
  • 0.0
Bacteria:S. pneumoniae, Other gram positive (i.e.: other streptococci, staphylococci, listeria …), Haemophilus influenzae, Other gram negative (i.e.: E. coli klebsiella, proteus, serratia, pseudomonas …), Legionella sp, Mycobacteria sp, Other Fungi: Candida sp, Aspergillus sp, Pneumocystis carinii, Other Parasites: Toxoplasma gondii, Other Viruses: HSV, VZV, EBV,CMV, HHV-6,RSV, Other respiratory virus (influenza, parainfluenza, rhinovirus), Adenovirus, HBV, HCV, HIV, Papovavirus, Parvovirus,Other

Uploaded:
2016-06-15 by Johannes Osterloh

You need to be logged in to download this form.


Discussion(0)
Comments (0)

    GRAFT VERSUS HOST DISEASE (GvHD) SINCE LAST REPORT

























    There are 2 more items that can be looked at in the detailed view










    There are 3 more items that can be looked at in the detailed view

    OTHER COMPLICATIONS SINCE LAST REPORT

















































    ADDITIONAL THERAPIES SINCE LAST FOLLOW UP












    10^8/kg



    x10^6/kg









    There are 4 more items that can be looked at in the detailed view









    LAST DISEASE AND PATIENT STATUS


















    There are 7 more items that can be looked at in the detailed view











    There are 13 more items that can be looked at in the detailed view

    S.0000

    EBMT PLASMA CELL DISORDERS (INCLUDING MULTIPLE MYELOMA)

    PLASMA CELL DISORDERS (INCLUDING MULTIPLE MYELOMA)

    Name: PLASMA CELL DISORDERS (INCLUDING MULTIPLE MYELOMA)
    Description: PLASMA CELL DISORDERS (INCLUDING MULTIPLE MYELOMA)

    Name Unique Identification Code (UIC)
    Question Unique Identification Code (UIC) (if known)
    Datatype text
    Aliases:  
    UMLS CUI [1] C2348585
    Name Hospital Unique Patient Number
    Question Hospital Unique Patient Number
    Datatype text
    Aliases:  
    UMLS CUI [1] C2348585
    Name Date of this report
    Question Date of this report
    Datatype date
    Aliases:  
    UMLS CUI [1] C1302584
    Name Patient in Trial
    Question Patient following national / international study / trial
    Datatype integer
    Aliases:  
    UMLS CUI [1] C1997894
    Codelistitems  
      No(1)
      Yes(2)
      Not evaluated(3)
      Unknown(4)
    Name Name of study / trial
    Question Name of study / trial
    Datatype text
    Aliases:  
    UMLS CUI [1] C0008976
    Name Initials
    Question First name(s)_surname(s)
    Datatype text
    Aliases:  
    UMLS CUI [1] C2986440
    Name Date of Birth
    Question Date of Birth
    Datatype date
    Aliases:  
    UMLS CUI [1] C0421451
    Name Date of last HSCT for this patient
    Question Date of last HSCT for this patient
    Datatype date
    Aliases:  
    UMLS CUI [1,1] C0472699
    UMLS CUI [1,2] C0011008

    PATIENT LAST SEEN

    Name: PATIENT LAST SEEN
    Description: PATIENT LAST SEEN

    Name Date last contact
    Question Date of Last Contact or Death
    Datatype date
    Aliases:  
    UMLS CUI [1] C0805839
    Name Complete haematological remission obtained after the HSCT in the absence of additional disease treatment
    Question Complete haematological remission obtained after the HSCT in the absence of additional disease treatment
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0677874
    Codelistitems  
      Previously reported(1)
    UMLS CUI-1: C0205309
      Yes, date(2)
    UMLS CUI-1: C1705108
      No (3)
    UMLS CUI-1: C1298908
      Unknown(4)
    UMLS CUI-1: C0439673

    GRAFT VERSUS HOST DISEASE (GvHD) SINCE LAST REPORT

    Name: GRAFT VERSUS HOST DISEASE (GvHD) SINCE LAST REPORT
    Description: GRAFT VERSUS HOST DISEASE (GvHD) SINCE LAST REPORT

    Name aGvHD Grade
    Question Acute Graft versus Host Disease (aGvHD) - Grade
    Datatype integer
    Aliases:  
    UMLS CUI [1,1] C0856825
    UMLS CUI [1,2] C0441800
    Codelistitems  
      grade 0 (Absent)(1)
      grade I(2)
      grade II(3)
      grade III(4)
      grade IV(5)
      Not evaluated(6)
      ...
      There are 1 more items on this list. Click to show them.
    Name ACUTE GRAFT VERSUS HOST DISEASE (AGVHD)
    Question ACUTE GRAFT VERSUS HOST DISEASE (AGVHD)
    Description If present
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0441799
    Codelistitems  
      New onset(New onset)
    UMLS CUI-1: C0746890
      Persistent(Persistent)
    UMLS CUI-1: C0205322
      Recurrent(Recurrent)
    UMLS CUI-1: C2945760
    Name aGvHD Reason
    Question aGvHD Reason
    Datatype integer
    Aliases:  
    UMLS CUI [1,1] C0856825
    UMLS CUI [1,2] M
    Codelistitems  
      Tapering(1)
    UMLS CUI-1: C0441640
      DLI(2)
    UMLS CUI-1: C1512034
      Unexplained(3)
    UMLS CUI-1: C0439673
    Name Date onset of this episode
    Question Date onset of this episode (if new or recurrent)
    Datatype date
    Aliases:  
    UMLS CUI [1] C0574845
    Measurement Units yyyy/mm/dd
    Name aGvHD Stage liver
    Question aGvHD Stage liver
    Datatype integer
    Aliases:  
    UMLS CUI [1] C1610054
    Codelistitems  
      None(0)
      Stage 1(1)
      Stage 2(2)
      Stage 3(3)
      Stage 4(4)
    Name aGvHD Stage skin
    Question aGvHD Stage skin
    Datatype integer
    Aliases:  
    UMLS CUI [1] C1610605
    Codelistitems  
      0(1)
      1(2)
      2(3)
      3(4)
      4(5)
      ...
      There are 2 more items on this list. Click to show them.
      Not evaluated(6)
      unknown(7)
    Name aGvHD Resolution
    Question aGvHD Resolution
    Datatype boolean
    Aliases:  
    UMLS CUI [1,1] C0856825
    UMLS CUI [1,2] C1514893
    Name aGvHD Date of resolution
    Question aGvHD Date of resolution
    Datatype date
    Aliases:  
    UMLS CUI [1,1] C0856825
    UMLS CUI [1,2] C1514893
    UMLS CUI [1,3] C0011008
    Measurement Units yyyy/mm/dd
    Name Chronic Graft versus Host Disease (cGvHD)
    Question Chronic Graft versus Host Disease (cGvHD)
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0867389
    Codelistitems  
      No(No)
      Present continuously since last reported episode(Present continuously since last reported episode)
      Resolved(Resolved)
      Yes(Yes)
    Name Chronic Graft versus Host Disease (cGvHD)
    Question Chronic Graft versus Host Disease (cGvHD)
    Description if yes...
    Datatype integer
    Aliases:  
    Codelistitems  
      First episode(1)
      Recurrence(2)
    Name Date of onset
    Question Date of onset
    Datatype date
    Aliases:  
    UMLS CUI [1] C0574845
    Name cGvHD grade
    Question If present continously since last report, specify cGvHD gade:
    Datatype text
    Aliases:  
    UMLS CUI [1,1] C0867389
    UMLS CUI [1,2] C0441799
    Codelistitems  
      Extensive(Extensive)
    UMLS CUI-1: C0205231
      Limited(Limited)
    UMLS CUI-1: C0439801
    Name cGvHD Organs affected
    Question cGvHD Organs affected
    Datatype integer
    Aliases:  
    UMLS CUI [1,1] C0867389
    UMLS CUI [1,2] C2095124
    Codelistitems  
      Skin(1)
    UMLS CUI-1: C1123023
      Gut(2)
    UMLS CUI-1: C0021853
      Liver(3)
    UMLS CUI-1: C0023884
      Mouth(4)
    UMLS CUI-1: C0230028
      Eyes(5)
    UMLS CUI-1: C0015392
      ...
      There are 3 more items on this list. Click to show them.
      Lung(6)
    UMLS CUI-1: C0024109
      Other, specify(7)
    UMLS CUI-1: C1299220
      Unknown(8)
    UMLS CUI-1: C0439673
    Name Date of Resolution
    Question If resolved, specify the date of resolution:
    Datatype date
    Aliases:  
    UMLS CUI [1,1] C1514893
    UMLS CUI [1,2] C0011008

    OTHER COMPLICATIONS SINCE LAST REPORT

    Name: OTHER COMPLICATIONS SINCE LAST REPORT
    Description: OTHER COMPLICATIONS SINCE LAST REPORT

    Name Infection related complications
    Question Infection related complications
    Datatype boolean
    Aliases:  
    UMLS CUI [1,1] C0009450
    UMLS CUI [1,2] C0009566
    Name ARDS
    Question
    Description Pathogen Use the list of pathogens listed after this table for guidance. Use “unknown” if necessary.
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0035222
    Codelistitems  
      Date(1)
      Pathogen(2)
    Name Pneumonia
    Question Pneumonia
    Description Provide different dates for different episodes of the same complication if applicable. Pathogen Use the list of pathogens listed after this table for guidance. Use “unknown” if necessary.
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0032285
    Codelistitems  
      Pathogen(1)
    UMLS CUI-1: C0450254
      Date(2)
    UMLS CUI-1: C0011008
    Name Hepatitis
    Question Hepatitis
    Description Use the list of pathogens listed after this table for guidance. Use “unknown” if necessary.
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0019158
    Codelistitems  
      Pathogen(1)
    UMLS CUI-1: C0450254
      Date(2)
    UMLS CUI-1: C0011008
    Name CNS infection
    Question CNS infection
    Description Pathogen Use the list of pathogens listed after this table for guidance. Use “unknown” if necessary. Provide different dates for different episodes of the same complication if applicable.
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0007684
    Codelistitems  
      Pathogen(1)
    UMLS CUI-1: C0450254
      Date(2)
    UMLS CUI-1: C0011008
    Name Gut infection
    Question Gut infection
    Description Pathogen Use the list of pathogens listed after this table for guidance. Use “unknown” if necessary. Date Provide different dates for different episodes of the same complication if applicable.
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0178238
    Codelistitems  
      Pathogen(1)
    UMLS CUI-1: C0450254
      Date(2)
    UMLS CUI-1: C0011008
    Name Skin infection
    Question Skin infection
    Description Pathogen Use the list of pathogens listed after this table for guidance. Use “unknown” if necessary. Date Provide different dates for different episodes of the same complication if applicable.
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0037278
    Codelistitems  
      Pathogen(1)
    UMLS CUI-1: C0450254
      Date(2)
    UMLS CUI-1: C0011008
    Name Cystitis
    Question Cystitis
    Description Pathogen Use the list of pathogens listed after this table for guidance. Use “unknown” if necessary. Date Provide different dates for different episodes of the same complication if applicable.
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0010692
    Codelistitems  
      Pathogen(1)
    UMLS CUI-1: C0450254
      Date(2)
    UMLS CUI-1: C0011008
    Name Retinitis
    Question Retinitis
    Description Pathogen Use the list of pathogens listed after this table for guidance. Use “unknown” if necessary. Date Provide different dates for different episodes of the same complication if applicable.
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0035333
    Codelistitems  
      Pathogen(1)
    UMLS CUI-1: C0450254
      Date(2)
    UMLS CUI-1: C0011008
      Unknown(3)
    UMLS CUI-1: C0439673
    Name Other
    Question Other
    Description Pathogen Use the list of pathogens listed after this table for guidance. Use “unknown” if necessary. Date Provide different dates for different episodes of the same complication if applicable.
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0205394
    Codelistitems  
      Pathogen(1)
    UMLS CUI-1: C0450254
      Date(2)
    UMLS CUI-1: C0011008
    Name Non infection related complications
    Question Non infection related complications
    Datatype boolean
    Aliases:  
    UMLS CUI [1] C0009566
    Name Idiopathic pneumonia syndrome
    Question Idiopathic pneumonia syndrome
    Datatype integer
    Aliases:  
    UMLS CUI [1] C1504431
    Codelistitems  
      Date(4)
      No (No )
      Unknown(Unknown)
      Yes(Yes)
    Name VOD
    Question VOD
    Description NON INFECTION RELATED COMPLICATIONS VOTCO100
    Datatype text
    Aliases:  
    UMLS CUI [1] C0948441
    Codelistitems  
      Date(Date)
      No (No )
      Unknown(Unknown)
      Yes(Yes)
    Name Cataract
    Question Cataract
    Description NON INFECTION RELATED COMPLICATIONS VOTCO100
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0086543
    Codelistitems  
      Date(4)
      No(No)
      Unknown(Unknown)
      Yes(Yes)
    Name Haemorrhagic cystitis, non infectious
    Question Haemorrhagic cystitis, non infectious
    Description NON INFECTION RELATED COMPLICATIONS VOTCO100
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0085692
    Codelistitems  
      Date(4)
      No (No )
      Unknown(Unknown)
      Yes (Yes )
    Name ARDS, non infectious
    Question ARDS, non infectious
    Description Specify:
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0035222
    Codelistitems  
      Date(4)
      No(No)
      Unknown(Unknown)
      Yes(Yes)
    Name Multiorgan failure, non infectious
    Question Multiorgan failure, non infectious
    Datatype integer
    Aliases:  
    Codelistitems  
      Yes(1)
      No(2)
      Unknown(3)
    Name HSCT-associated microangiopathy
    Question HSCT-associated microangiopathy
    Description Specify:
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0155765
    Codelistitems  
      Date(4)
      No(No)
      Unknown(Unknown)
      Yes(Yes)
    Name Renal failure requiring dialysis
    Question Renal failure requiring dialysis
    Description NON INFECTION RELATED COMPLICATIONS VOTCO100
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0035078
    Codelistitems  
      Date(4)
      No(No)
      Unknown(Unknown)
      Yes(Yes)
    Name Haemolytic anaemia due to blood group
    Question Haemolytic anaemia due to blood group
    Description NON INFECTION RELATED COMPLICATIONS VOTCO100
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0002878
    Codelistitems  
      Date(4)
      No(No)
      Unknown(Unknown)
      Yes(Yes)
    Name Aseptic bone necrosis
    Question Aseptic bone necrosis
    Description NON INFECTION RELATED COMPLICATIONS VOTCO100
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0158452
    Codelistitems  
      Date(4)
      No(No)
      Unknown(Unknown)
      Yes(Yes)
    Name Graft loss
    Question Graft loss
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0877042
    Codelistitems  
      No(1)
      Yes(2)
      Not evaluated(3)
    Name Overall Chimerism
    Question Overall Chimerism
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0333678
    Codelistitems  
      Full (donor > 95%)(1)
    UMLS CUI-1: C0333678
      Mixed (partial)(2)
    UMLS CUI-1: C3160715
      Autologuos reconstitution (recipient > 95%)(3)
    UMLS CUI-1: C0301944
      Aplasia(4)
    UMLS CUI-1: C0243065
      Not evaluated(5)
    UMLS CUI-1: C3846720
    Name Identification
    Question Identification of donor or Cord Blood Unit given by the centre
    Datatype text
    Aliases:  
    UMLS CUI [1] C1718162
    Name Date of Test
    Question Date of Test
    Datatype date
    Aliases:  
    UMLS CUI [1,1] C0024671
    UMLS CUI [1,2] C0011008
    Name Number in the infusion order (if applicable)
    Question Number in the infusion order (if applicable)
    Datatype integer
    Aliases:  
    UMLS CUI [1] C2348184
    Codelistitems  
      .........(1)
      N/A(2)
    Name Bone marrow
    Question Cell type on which test was performed (% Donor Cells): BM
    Datatype float
    Aliases:  
    UMLS CUI [1] C0005953
    Measurement Units %
    Name PB mononuclear cells (PBMC)
    Question Cell type on which test was performed (% Donor cells): PB mononuclear cells (PBMC)
    Datatype float
    Aliases:  
    UMLS CUI [1] C1321301
    Measurement Units %
    Name B-Cells
    Question Cell type on which test was performed (% Donor cells): B-Cells
    Datatype float
    Aliases:  
    UMLS CUI [1] C0004561
    Measurement Units %
    Name Red blood cells
    Question Cell type on which test was performed (% Donor cells): Red blood cells
    Datatype float
    Aliases:  
    UMLS CUI [1] C0014772
    Measurement Units %
    Name Monocytes
    Question Cell type on which test was performed (% Donor cells): Monocytes
    Datatype float
    Aliases:  
    UMLS CUI [1] C0026473
    Measurement Units %
    Name PMNs (neutrophils)
    Question Cell type on which test was performed (% Donor cells): PMNs (neutrophils)
    Datatype float
    Aliases:  
    UMLS CUI [1] C0200633
    Measurement Units %
    Name Lymphocytes, NOS
    Question Cell type on which test was performed (% Donor cells): Lymphocytes, NOS
    Datatype float
    Aliases:  
    UMLS CUI [1] C0024264
    Measurement Units %
    Name Myeloid cells, NOS
    Question Cell type on which test was performed (% Donor cells): Myeloid cells, NOS
    Datatype float
    Aliases:  
    UMLS CUI [1] C0887899
    Measurement Units %
    Name Other
    Question Cell type on which test was performed
    Datatype text
    Aliases:  
    Name SECONDARY MALIGNANCY, LYMPHOPROLIFERATIVE OR MYELOPROLIFRATIVE DISORDER DIAGNOSED
    Question SECONDARY MALIGNANCY, LYMPHOPROLIFERATIVE OR MYELOPROLIFRATIVE DISORDER DIAGNOSED
    Datatype integer
    Aliases:  
    Codelistitems  
      No at date of this follow-up(No at date of this follow-up)
      Previously reported(Previously reported)
      Yes(Yes)
    Name Date of diagnosis
    Question If yes, specify date of diagnosis
    Datatype date
    Aliases:  
    UMLS CUI [1] C2316983
    Name Diagnosis
    Question SECONDARY MALIGNANCY, LYMPHOPROLIFERATIVE OR MYELOPROLIFRATIVE DISORDER DIAGNOSED
    Datatype text
    Aliases:  
    Codelistitems  
      AML(AML)
      Lymphoproliferative disorder(Lymphoproliferative disorder)
      MDS(MDS)
      Other(Other)
    Name Diagnosis
    Question if other, please specify
    Datatype text
    Aliases:  

    ADDITIONAL THERAPIES SINCE LAST FOLLOW UP

    Name: ADDITIONAL THERAPIES SINCE LAST FOLLOW UP
    Description: ADDITIONAL THERAPIES SINCE LAST FOLLOW UP

    Name ADDITIONAL Therapy SINCE LAST FOLLOW UP
    Question ADDITIONAL Therapy SINCE LAST FOLLOW UP
    Datatype text
    Aliases:  
    UMLS CUI [1] C1706712
    Codelistitems  
      No(No)
      Unknown(Unknown)
      Yes, date started(Yes, date started)
    Name Date started
    Question Date ADDITIONAL THERAPIES SINCE LAST FOLLOW UP started
    Datatype date
    Aliases:  
    UMLS CUI [1,1] C1706712
    UMLS CUI [1,2] C0808070
    Name if yes, Disease status before this cellular therapy
    Question if yes, Disease status before this cellular therapy
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0018759
    Codelistitems  
      CR(CR)
    UMLS CUI-1: C0677874
      Not evaluated(Not evaluated)
    UMLS CUI-1: C3846720
      Not in CR(Not in CR)
    UMLS CUI-1: C0677874
    Name Type of cells
    Question If yes: Type of cells
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0302189
    Codelistitems  
      Donor lymphocyte infusion (DLI)(1)
    UMLS CUI-1: C1512034
      Mesenchymal cells(2)
    UMLS CUI-1: C1257975
      Other(3)
    UMLS CUI-1: C0205394
      Unknown(4)
    UMLS CUI-1: C0439673
    Name Number of cells infused by type
    Question Number of cells infused by type
    Datatype integer
    Aliases:  
    Measurement Units 10^8/kg
    Codelistitems  
      Number of Nucleated cells infused (DLI only)(1)
    UMLS CUI-1: C1180059
      CD 34+ (cells/kg*) (DLI only)(2)
    UMLS CUI-1: C1955216
      CD 3+ (cells/kg*) (DLI only)(3)
    UMLS CUI-1: C0483189
    Name All cells
    Question Total number of cells infused (non DLI only)
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0007584
    Measurement Units x10^6/kg
    Codelistitems  
      Number(1)
      Not evaluated(2)
      Unknown(3)
    Name Chronological number
    Question Chronological number of this cell therapy for this patient
    Datatype float
    Aliases:  
    UMLS CUI [1] C2348184
    Name Indication
    Question Indication (check all that apply)
    Description (check all that apply)
    Datatype integer
    Aliases:  
    UMLS CUI [1,1] C3146298
    UMLS CUI [1,2] C0302189
    Codelistitems  
      Loss/decreased chimaerism(Loss/decreased chimaerism)
      Mixed chimaerism(Mixed chimaerism)
      Other(Other)
      Planned/ protocol(Planned/ protocol)
      Prophylactic(Prophylactic)
      ...
      There are 4 more items on this list. Click to show them.
      Treatment for disease(Treatment for disease)
      Treatment of GvHD(Treatment of GvHD)
      Treatment PTLD, EBV, lymphoma(Treatment PTLD, EBV, lymphoma)
      Treatment viral infection(Treatment viral infection)
    Name Acute Graft versus Host Disease
    Question Acute Graft versus Host Disease
    Description Maximum grade:(after this infusion but before any further infusion/ transplant)
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0856825
    Codelistitems  
      grade 0 (absent)(grade 0 (absent))
      grade 1(grade 1)
      grade 2(grade 2)
      grade 3(grade 3)
      grade 4(grade 4)
      present, grade unknown(present, grade unknown)
      ...
      There are 1 more items on this list. Click to show them.
    Name Disease treatment
    Question Disease treatment (apart from donor cell infusion or other type of cell therapy)
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0087111
    Codelistitems  
      No(1)
      Yes: Planned (planned before HSCT took place)(2)
      Yes: Not planned (for relapse/progression or persistent disease)(3)

    FIRST EVIDENCE OF RELAPSE OR PROGRESSION SINCE LAST HSCT

    Name: FIRST EVIDENCE OF RELAPSE OR PROGRESSION SINCE LAST HSCT
    Description: FIRST EVIDENCE OF RELAPSE OR PROGRESSION SINCE LAST HSCT

    Name Relapse or Progression
    Question Relapse or Progression
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0277556
    UMLS CUI [2] C0242656
    Codelistitems  
      Continous progression since transplant(Continous progression since transplant)
    UMLS CUI-1: C0242656
      No(No)
    UMLS CUI-1: C1298908
      Previously reported(Previously reported)
    UMLS CUI-1: C0205309
      Unknown(Unknown)
    UMLS CUI-1: C0439673
      Yes(Yes)
    UMLS CUI-1: C1705108
    Name If yes, date diagnosed
    Question If yes, date diagnosed RELAPSE OR PROGRESSION
    Datatype date
    Aliases:  
    UMLS CUI [1,1] C0035020
    UMLS CUI [1,2] C2316983

    LAST DISEASE AND PATIENT STATUS

    Name: LAST DISEASE AND PATIENT STATUS
    Description: LAST DISEASE AND PATIENT STATUS

    Name Last Disease Status
    Question last disease status
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0421168
    Codelistitems  
      Complete Remission(Complete Remission)
    UMLS CUI-1: C0677874
      Relapse(Relapse)
    UMLS CUI-1: C0277556
      Stable disease(Stable disease)
    UMLS CUI-1: C0677946
      Treatment failure/ progression(Treatment failure/ progression)
    UMLS CUI-1: C0242656
    Name Conception
    Question Has patient or partner become pregnant after this HSCT?
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0032961
    Codelistitems  
      No(No)
      Unknown(Unknown)
      Yes(Yes)
    Name Survival Status
    Question Survival Status
    Datatype integer
    Aliases:  
    UMLS CUI [1] C1148433
    Codelistitems  
      alive(0)
      dead(1)
    Name If alive: Type of score used:
    Question If alive: Type of score used:
    Datatype integer
    Aliases:  
    UMLS CUI [1] C1518965
    Codelistitems  
      Karnofsky(Karnofsky)
      Lansky(Lansky)
      Not evaluated(Not evaluated)
      Unknown(Unknown)
    Name Performance score
    Question Performance score
    Datatype integer
    Aliases:  
    UMLS CUI [1] C1518965
    Codelistitems  
      100 (Normal, NED)(1)
      10 (Moribund)(10)
      Not evaluated(11)
      Unknown(12)
      90 (Normal activity) (2)
      ...
      There are 7 more items on this list. Click to show them.
      80 (Normal with effort)(3)
      70 (Cares for self)(4)
      60 (Requires occasional assistance)(5)
      50 (Requires assistance)(6)
      40 (Disabled)(7)
      30 (Severely disabled)(8)
      20 (Very sick)(9)
    Name CAUSE OF DEATH
    Question CAUSE OF DEATH
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0007465
    Codelistitems  
      HSCT related cause(HSCT related cause)
    UMLS CUI-1: C0472699
    UMLS CUI-2: C0007465
      Other(Other)
    UMLS CUI-1: C0205394
      Relapse or progression(Relapse or progression)
    UMLS CUI-1: C0277556
    UMLS CUI-2: C0242656
      Secondary malignancy(Secondary malignancy)
    UMLS CUI-1: C3266877
      Unknown(Unknown)
    UMLS CUI-1: C0439673
    Name HSCT related cause of death
    Question HSCT related cause of death
    Datatype integer
    Aliases:  
    UMLS CUI [1,1] C0007465
    UMLS CUI [1,2] C0472699
    Codelistitems  
      GvHD(1)
    UMLS CUI-1: C0018133
      Veno-occlusive disease (VOD)(10)
    UMLS CUI-1: C0948441
      Haemorrhage(11)
    UMLS CUI-1: C0019080
      Cardiac toxicity(12)
    UMLS CUI-1: C0876994
      Central nervous system toxicity(13)
    UMLS CUI-1: C3160947
      ...
      There are 13 more items on this list. Click to show them.
      Gastro intestinal toxicity(14)
    UMLS CUI-1: C0007465
    UMLS CUI-2: C1142499
      Skin toxicity(15)
    UMLS CUI-1: C1167791
      Renal failure(16)
    UMLS CUI-1: C1533077
      Multiple organ failure(17)
    UMLS CUI-1: C0026766
      Other(18)
    UMLS CUI-1: C0205394
      Interstitial pneumonitis(2)
    UMLS CUI-1: C0206061
      Pulmonary toxicity(3)
    UMLS CUI-1: C0919924
      Infection bacterial(4)
    UMLS CUI-1: C0004623
      Infection viral(5)
    UMLS CUI-1: C0042769
      Infection fungal(6)
    UMLS CUI-1: C0026946
      Infection parasitic(7)
    UMLS CUI-1: C0030498
      Infection unknown(8)
    UMLS CUI-1: C0009450
      Rejection / poor graft function(9)
    UMLS CUI-1: C1268811

    ADDITIONAL NOTES IF APPLICABLE

    Name: ADDITIONAL NOTES IF APPLICABLE
    Description: ADDITIONAL NOTES IF APPLICABLE

    Name Comments
    Question Comments
    Datatype integer
    Aliases:  
    UMLS CUI [1] C0947611
    Name IDENTIFICATION & SIGNATURE
    Question IDENTIFICATION & SIGNATURE
    Datatype integer
    Aliases:  
    UMLS CUI [1,1] C0205396
    UMLS CUI [1,2] C1519316

When you register and login you can access the downloads of this form in any of the following formats. All downloads include a license and a metadata file.

  • ODM-XML
    • This format gives you the original XML-file that was uploaded by the user. If the file originally contained sensitive patient data, these data have been removed automatically.
  • PDF
    • You get a PDF that appears similar to the default view of the form, as it can be viewed on the first tab
  • PDF (with comments)
    • You get a PDF that appears similar to the default view of the form, as it can be viewed on the first tab and that is annotated with all the comments our users have made to the form and its elements.
  • CDA
    • This download format gets you a file in the XML-based CDA format (Clinical Document Architecture) that allows you to import the form into systems that support this format. CDA was made to ease the storage and exchange of clinical documents.
  • CSV
    • This format will get you a CSV-file that you can easily import into the spreadsheet program of your choice.
  • FHIR (Json)
    • This format gets you a file in Fast Healthcare Interoperable Resources (FHIR)-standard. You can choose between XML and JSON-Format (this download).
  • FHIR (RDF)
    • This format gets you a file in Fast Healthcare Interoperable Resources (FHIR)-standard. You can choose between XML, RDF (this download) and JSON-Format.
  • FHIR (XML)
    • This format gets you a file in Fast Healthcare Interoperable Resources (FHIR)-standard. You can choose between XML (this download) and JSON-Format.
  • MACRO-XML
    • This download gets you an XML-file in MACRO-format, that can easily be imported into you MACRO system and be used to gather data.
  • Open Data Kit
    • This download format gets you a file that can be imported into and looked at in your ODK program. Before you do so, you just need to convert the file to XLSForm format (http://opendatakit.org/xiframe/). ODK is a collection of open-source tools to gather data.
  • OpenClinica
    • OpenClinica is an open source software that is used for Electronic Data Capture (EDC) and Clinical Data Management (CDM). Downloading the form in this format will allow you to easily import it into your OpenClinica environment.
  • REDCap
    • Choose this format if you want to use this form in REDCap (Research Electronic Data Capture). REDCap allows you to create databases and surveys for data collection.
  • ResearchKit
    • ResearchKit is an open-source framework that is meant to ease the data collection for patients or study participants. Downloading the form in this format allows you to easily import it into your ResearchKit app or program.
  • ResearchKit Swift
    • ResearchKit is an open-source framework that is meant to ease the data collection for patients or study participants. Downloading the form in this format allows you to easily import it into your ResearchKit app or program using swift.
  • SQL
    • A download in the SQL format allows you to easily import the form into your SQL-based Databases.
  • SPSS
    • The download in SPS-format gets you a file that can easily be imported into your SPSS statistics and -analysis program.
  • ADL
    • You get a form in ADL-format (Archetype Definition Language) that can easily be imported into your ADL Workbench.
  • R
    • Downloading the form in this format makes it easily accessible in R which allows for statistical analyses.
  • XLSX
    • The XLSX format can easily be imported into the spreadsheet program of your choice.
CC BY-NC 3.0

License

THE WORK (AS DEFINED BELOW) IS PROVIDED UNDER THE TERMS OF THIS CREATIVE COMMONS PUBLIC LICENSE ("CCPL" OR "LICENSE"). THE WORK IS PROTECTED BY COPYRIGHT AND/OR OTHER APPLICABLE LAW. ANY USE OF THE WORK OTHER THAN AS AUTHORIZED UNDER THIS LICENSE OR COPYRIGHT LAW IS PROHIBITED.

BY EXERCISING ANY RIGHTS TO THE WORK PROVIDED HERE, YOU ACCEPT AND AGREE TO BE BOUND BY THE TERMS OF THIS LICENSE. TO THE EXTENT THIS LICENSE MAY BE CONSIDERED TO BE A CONTRACT, THE LICENSOR GRANTS YOU THE RIGHTS CONTAINED HERE IN CONSIDERATION OF YOUR ACCEPTANCE OF SUCH TERMS AND CONDITIONS.

1. Definitions

  1. "Adaptation" means a work based upon the Work, or upon the Work and other pre-existing works, such as a translation, adaptation, derivative work, arrangement of music or other alterations of a literary or artistic work, or phonogram or performance and includes cinematographic adaptations or any other form in which the Work may be recast, transformed, or adapted including in any form recognizably derived from the original, except that a work that constitutes a Collection will not be considered an Adaptation for the purpose of this License. For the avoidance of doubt, where the Work is a musical work, performance or phonogram, the synchronization of the Work in timed-relation with a moving image ("synching") will be considered an Adaptation for the purpose of this License.
  2. "Collection" means a collection of literary or artistic works, such as encyclopedias and anthologies, or performances, phonograms or broadcasts, or other works or subject matter other than works listed in Section 1(f) below, which, by reason of the selection and arrangement of their contents, constitute intellectual creations, in which the Work is included in its entirety in unmodified form along with one or more other contributions, each constituting separate and independent works in themselves, which together are assembled into a collective whole. A work that constitutes a Collection will not be considered an Adaptation (as defined above) for the purposes of this License.
  3. "Distribute" means to make available to the public the original and copies of the Work or Adaptation, as appropriate, through sale or other transfer of ownership.
  4. "Licensor" means the individual, individuals, entity or entities that offer(s) the Work under the terms of this License.
  5. "Original Author" means, in the case of a literary or artistic work, the individual, individuals, entity or entities who created the Work or if no individual or entity can be identified, the publisher; and in addition (i) in the case of a performance the actors, singers, musicians, dancers, and other persons who act, sing, deliver, declaim, play in, interpret or otherwise perform literary or artistic works or expressions of folklore; (ii) in the case of a phonogram the producer being the person or legal entity who first fixes the sounds of a performance or other sounds; and, (iii) in the case of broadcasts, the organization that transmits the broadcast.
  6. "Work" means the literary and/or artistic work offered under the terms of this License including without limitation any production in the literary, scientific and artistic domain, whatever may be the mode or form of its expression including digital form, such as a book, pamphlet and other writing; a lecture, address, sermon or other work of the same nature; a dramatic or dramatico-musical work; a choreographic work or entertainment in dumb show; a musical composition with or without words; a cinematographic work to which are assimilated works expressed by a process analogous to cinematography; a work of drawing, painting, architecture, sculpture, engraving or lithography; a photographic work to which are assimilated works expressed by a process analogous to photography; a work of applied art; an illustration, map, plan, sketch or three-dimensional work relative to geography, topography, architecture or science; a performance; a broadcast; a phonogram; a compilation of data to the extent it is protected as a copyrightable work; or a work performed by a variety or circus performer to the extent it is not otherwise considered a literary or artistic work.
  7. "You" means an individual or entity exercising rights under this License who has not previously violated the terms of this License with respect to the Work, or who has received express permission from the Licensor to exercise rights under this License despite a previous violation.
  8. "Publicly Perform" means to perform public recitations of the Work and to communicate to the public those public recitations, by any means or process, including by wire or wireless means or public digital performances; to make available to the public Works in such a way that members of the public may access these Works from a place and at a place individually chosen by them; to perform the Work to the public by any means or process and the communication to the public of the performances of the Work, including by public digital performance; to broadcast and rebroadcast the Work by any means including signs, sounds or images.
  9. "Reproduce" means to make copies of the Work by any means including without limitation by sound or visual recordings and the right of fixation and reproducing fixations of the Work, including storage of a protected performance or phonogram in digital form or other electronic medium.

2. Fair Dealing Rights. Nothing in this License is intended to reduce, limit, or restrict any uses free from copyright or rights arising from limitations or exceptions that are provided for in connection with the copyright protection under copyright law or other applicable laws.

3. License Grant. Subject to the terms and conditions of this License, Licensor hereby grants You a worldwide, royalty-free, non-exclusive, perpetual (for the duration of the applicable copyright) license to exercise the rights in the Work as stated below:

  1. to Reproduce the Work, to incorporate the Work into one or more Collections, and to Reproduce the Work as incorporated in the Collections;
  2. to create and Reproduce Adaptations provided that any such Adaptation, including any translation in any medium, takes reasonable steps to clearly label, demarcate or otherwise identify that changes were made to the original Work. For example, a translation could be marked "The original work was translated from English to Spanish," or a modification could indicate "The original work has been modified.";
  3. to Distribute and Publicly Perform the Work including as incorporated in Collections; and,
  4. to Distribute and Publicly Perform Adaptations.

The above rights may be exercised in all media and formats whether now known or hereafter devised. The above rights include the right to make such modifications as are technically necessary to exercise the rights in other media and formats. Subject to Section 8(f), all rights not expressly granted by Licensor are hereby reserved, including but not limited to the rights set forth in Section 4(d).

4. Restrictions. The license granted in Section 3 above is expressly made subject to and limited by the following restrictions:

  1. You may Distribute or Publicly Perform the Work only under the terms of this License. You must include a copy of, or the Uniform Resource Identifier (URI) for, this License with every copy of the Work You Distribute or Publicly Perform. You may not offer or impose any terms on the Work that restrict the terms of this License or the ability of the recipient of the Work to exercise the rights granted to that recipient under the terms of the License. You may not sublicense the Work. You must keep intact all notices that refer to this License and to the disclaimer of warranties with every copy of the Work You Distribute or Publicly Perform. When You Distribute or Publicly Perform the Work, You may not impose any effective technological measures on the Work that restrict the ability of a recipient of the Work from You to exercise the rights granted to that recipient under the terms of the License. This Section 4(a) applies to the Work as incorporated in a Collection, but this does not require the Collection apart from the Work itself to be made subject to the terms of this License. If You create a Collection, upon notice from any Licensor You must, to the extent practicable, remove from the Collection any credit as required by Section 4(c), as requested. If You create an Adaptation, upon notice from any Licensor You must, to the extent practicable, remove from the Adaptation any credit as required by Section 4(c), as requested.
  2. You may not exercise any of the rights granted to You in Section 3 above in any manner that is primarily intended for or directed toward commercial advantage or private monetary compensation. The exchange of the Work for other copyrighted works by means of digital file-sharing or otherwise shall not be considered to be intended for or directed toward commercial advantage or private monetary compensation, provided there is no payment of any monetary compensation in connection with the exchange of copyrighted works.
  3. If You Distribute, or Publicly Perform the Work or any Adaptations or Collections, You must, unless a request has been made pursuant to Section 4(a), keep intact all copyright notices for the Work and provide, reasonable to the medium or means You are utilizing: (i) the name of the Original Author (or pseudonym, if applicable) if supplied, and/or if the Original Author and/or Licensor designate another party or parties (e.g., a sponsor institute, publishing entity, journal) for attribution ("Attribution Parties") in Licensor's copyright notice, terms of service or by other reasonable means, the name of such party or parties; (ii) the title of the Work if supplied; (iii) to the extent reasonably practicable, the URI, if any, that Licensor specifies to be associated with the Work, unless such URI does not refer to the copyright notice or licensing information for the Work; and, (iv) consistent with Section 3(b), in the case of an Adaptation, a credit identifying the use of the Work in the Adaptation (e.g., "French translation of the Work by Original Author," or "Screenplay based on original Work by Original Author"). The credit required by this Section 4(c) may be implemented in any reasonable manner; provided, however, that in the case of a Adaptation or Collection, at a minimum such credit will appear, if a credit for all contributing authors of the Adaptation or Collection appears, then as part of these credits and in a manner at least as prominent as the credits for the other contributing authors. For the avoidance of doubt, You may only use the credit required by this Section for the purpose of attribution in the manner set out above and, by exercising Your rights under this License, You may not implicitly or explicitly assert or imply any connection with, sponsorship or endorsement by the Original Author, Licensor and/or Attribution Parties, as appropriate, of You or Your use of the Work, without the separate, express prior written permission of the Original Author, Licensor and/or Attribution Parties.
  4. For the avoidance of doubt:

    1. Non-waivable Compulsory License Schemes. In those jurisdictions in which the right to collect royalties through any statutory or compulsory licensing scheme cannot be waived, the Licensor reserves the exclusive right to collect such royalties for any exercise by You of the rights granted under this License;
    2. Waivable Compulsory License Schemes. In those jurisdictions in which the right to collect royalties through any statutory or compulsory licensing scheme can be waived, the Licensor reserves the exclusive right to collect such royalties for any exercise by You of the rights granted under this License if Your exercise of such rights is for a purpose or use which is otherwise than noncommercial as permitted under Section 4(b) and otherwise waives the right to collect royalties through any statutory or compulsory licensing scheme; and,
    3. Voluntary License Schemes. The Licensor reserves the right to collect royalties, whether individually or, in the event that the Licensor is a member of a collecting society that administers voluntary licensing schemes, via that society, from any exercise by You of the rights granted under this License that is for a purpose or use which is otherwise than noncommercial as permitted under Section 4(c).
  5. Except as otherwise agreed in writing by the Licensor or as may be otherwise permitted by applicable law, if You Reproduce, Distribute or Publicly Perform the Work either by itself or as part of any Adaptations or Collections, You must not distort, mutilate, modify or take other derogatory action in relation to the Work which would be prejudicial to the Original Author's honor or reputation. Licensor agrees that in those jurisdictions (e.g. Japan), in which any exercise of the right granted in Section 3(b) of this License (the right to make Adaptations) would be deemed to be a distortion, mutilation, modification or other derogatory action prejudicial to the Original Author's honor and reputation, the Licensor will waive or not assert, as appropriate, this Section, to the fullest extent permitted by the applicable national law, to enable You to reasonably exercise Your right under Section 3(b) of this License (right to make Adaptations) but not otherwise.

5. Representations, Warranties and Disclaimer

UNLESS OTHERWISE MUTUALLY AGREED TO BY THE PARTIES IN WRITING, LICENSOR OFFERS THE WORK AS-IS AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE WORK, EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, INCLUDING, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTIBILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OF ABSENCE OF ERRORS, WHETHER OR NOT DISCOVERABLE. SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES, SO SUCH EXCLUSION MAY NOT APPLY TO YOU.

6. Limitation on Liability. EXCEPT TO THE EXTENT REQUIRED BY APPLICABLE LAW, IN NO EVENT WILL LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY FOR ANY SPECIAL, INCIDENTAL, CONSEQUENTIAL, PUNITIVE OR EXEMPLARY DAMAGES ARISING OUT OF THIS LICENSE OR THE USE OF THE WORK, EVEN IF LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

7. Termination

  1. This License and the rights granted hereunder will terminate automatically upon any breach by You of the terms of this License. Individuals or entities who have received Adaptations or Collections from You under this License, however, will not have their licenses terminated provided such individuals or entities remain in full compliance with those licenses. Sections 1, 2, 5, 6, 7, and 8 will survive any termination of this License.
  2. Subject to the above terms and conditions, the license granted here is perpetual (for the duration of the applicable copyright in the Work). Notwithstanding the above, Licensor reserves the right to release the Work under different license terms or to stop distributing the Work at any time; provided, however that any such election will not serve to withdraw this License (or any other license that has been, or is required to be, granted under the terms of this License), and this License will continue in full force and effect unless terminated as stated above.

8. Miscellaneous

  1. Each time You Distribute or Publicly Perform the Work or a Collection, the Licensor offers to the recipient a license to the Work on the same terms and conditions as the license granted to You under this License.
  2. Each time You Distribute or Publicly Perform an Adaptation, Licensor offers to the recipient a license to the original Work on the same terms and conditions as the license granted to You under this License.
  3. If any provision of this License is invalid or unenforceable under applicable law, it shall not affect the validity or enforceability of the remainder of the terms of this License, and without further action by the parties to this agreement, such provision shall be reformed to the minimum extent necessary to make such provision valid and enforceable.
  4. No term or provision of this License shall be deemed waived and no breach consented to unless such waiver or consent shall be in writing and signed by the party to be charged with such waiver or consent.
  5. This License constitutes the entire agreement between the parties with respect to the Work licensed here. There are no understandings, agreements or representations with respect to the Work not specified here. Licensor shall not be bound by any additional provisions that may appear in any communication from You. This License may not be modified without the mutual written agreement of the Licensor and You.
  6. The rights granted under, and the subject matter referenced, in this License were drafted utilizing the terminology of the Berne Convention for the Protection of Literary and Artistic Works (as amended on September 28, 1979), the Rome Convention of 1961, the WIPO Copyright Treaty of 1996, the WIPO Performances and Phonograms Treaty of 1996 and the Universal Copyright Convention (as revised on July 24, 1971). These rights and subject matter take effect in the relevant jurisdiction in which the License terms are sought to be enforced according to the corresponding provisions of the implementation of those treaty provisions in the applicable national law. If the standard suite of rights granted under applicable copyright law includes additional rights not granted under this License, such additional rights are deemed to be included in the License; this License is not intended to restrict the license of any rights under applicable law.